Patent Assignment
Reel/Frame 066805/0346
Patent Security Agreement
Recorded: 2024-03-18
Pages: 15
Assignor
UROGEN PHARMA LTD.
Executed: 2024-03-18
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(30)
Material and Method for Treating Internal Cavities
Application:
17/566,882 →
Publication:
US 2022/0118096
Material and Method for Treating Internal Cavities
Application:
18/129,497 →
Publication:
US 2023/0241220
Material and Method for Treating Internal Cavities
Application:
18/129,508 →
Publication:
US 2023/0241221
Material and Method for Treating Internal Cavities
Application:
18/129,543 →
Publication:
US 2023/0233685
Immunomodulating Treatments of Body Cavities
Application:
17/006,926 →
Publication:
US 2020/0397695
Immunomodulating Treatments of Body Cavities
Application:
18/180,152 →
Publication:
US 2023/0218521
Material and Method for Treating Cancer
Compositions Comprising a Thermoreversible Hydrogel, and Having an Extended in-Use Period
Application:
63/411,024 →
Compositions Comprising a Thermoreversible Hydrogel, and Having an Extended in-Use Period
Application:
18/374,645 →
Publication:
US 2024/0100019
Immunomodulating Treatments of Body Cavities
Application:
63/502,418 →
Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with a Reverse Thermal Gel Containing Mitomycin
Application:
63/515,352 →
Material and Method for Treating Internal Cavities
Material and Method for Treating Internal Cavities
Material and Method for Treating Internal Cavities
Material and Method for Treating Internal Cavities
Biocompatible Drug Delivery Apparatus and Methods
Methods for Treatment of Bladder Cancer
Biocompatible Drug Delivery Apparatus and Methods
Methods for Treatment of Bladder Cancer
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent:
9,801,854 →
Application:
14/600,354 →
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Immunomodulating Treatments of Body Cavities
Thermosensitive Bio-Adhesive Hydrogel for Removal of Ureteral and Renal Stones
A Connectable Catheter
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2004
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 015817/0081 →
Assignment of Assignor's Interest
Sep 19, 2011
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 026930/0047 →
Assignment of Assignor's Interest
Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest
Jun 13, 2013
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 030605/0477 →
Assignment of Assignor's Interest
Jun 20, 2013
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 030655/0891 →
Assignment of Assignor's Interest
Jan 9, 2014
From: KONORTY, MARINA; HAKIM, GIL
To: THERACOAT LTD
Reel/Frame 031947/0586 →
Asset Purchase Agreement
Nov 13, 2015
From: TELORMEDIX SA
To: THERACOAT LTD.
Reel/Frame 037109/0769 →
Change of Name
Nov 13, 2015
From: THERACOAT LTD
To: UROGEN PHARMA LTD
Reel/Frame 037111/0567 →
Change of Name
Nov 24, 2015
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037135/0053 →
Change of Name
Jan 19, 2016
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037553/0678 →
Assignment of Assignor's Interest
Feb 4, 2016
From: TELORMEDIX, SA
To: UROGEN PHARMA LTD.
Reel/Frame 037668/0353 →
Change of Name
Jan 8, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045016/0287 →
Assignment of Assignor's Interest
Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Assignment of Assignor's Interest
Dec 31, 2020
From: HAKIM, GIL; STRAUSS-AYALI, DALIT; FRIEDMAN, ASTAR; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 054782/0820 →
Change of Name
Mar 15, 2021
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 055588/0095 →
Security Interest
Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Assignment of Assignor's Interest
Apr 7, 2022
From: HIONIDI, YULIA; TSIPORI, OMER; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059528/0317 →
Assignment of Assignor's Interest
Apr 29, 2022
From: KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059774/0318 →
Assignment of Assignor's Interest
May 2, 2022
From: KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059760/0394 →
Amended and Restated Patent Security Agreement
May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Assignment of Assignor's Interest
Mar 23, 2023
From: HAKIM, GIL; STRAUSS-AYALI, DALIT; FRIEDMAN, ASTAR; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 063072/0794 →
Patent Security Agreement
Aug 18, 2023
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064641/0263 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Amended and Restated Patent Security Agreement
Aug 18, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072472/0233 →